Panmnesia vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Panmnesia

EmergingArtificial Intelligence

CXL Memory Switch Silicon

Raised $80M+ total. CXL 3.1 Switch silicon chip in fab. $30M government project for chiplet AI accelerators. Pure-play CXL switch chip company for AI memory pooling.

About

Panmnesia is a pure-play CXL (Compute Express Link) switch chip company developing the silicon fabric that allows AI systems to pool, share, and disaggregate memory across heterogeneous compute nodes. The company has raised $80 million+ in total financing with its CXL 3.1 switch chip entering fabrication, and received a $30 million government project to develop chiplet-based AI accelerators using CXL memory interconnects.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.